ResultsIQ

ResultsIQ › Latest results › Valiant Organics Limited

Valiant Organics Limited Q4 FY25 results deck summary

NSE: VALIANTORG · BSE: 540145

Results deck of 30 May 2025, summarised by AI from the filing.

Valiant Organics Q4 FY25 revenue rose 15.3% YoY to ₹2,038 mn, with EBITDA at ₹203 mn and PAT at ₹42 mn.

Key takeaways

  1. Q4 FY25 revenue Revenue from operations was ₹2,038 mn, up 15.3% YoY from ₹1,768 mn.
  2. FY25 EBITDA EBITDA was ₹537 mn, up 40.6% YoY from ₹382 mn, with margin at 7.47%.
  3. Gross margin FY25 gross profit margin expanded to 37% from 33% in FY24.
  4. FY25 PAT FY25 PAT remained negative at ₹(34) mn, though improved from ₹(84) mn in FY24.

Original filing on BSE

Valiant Organics Limited Q1 FY27 results

As filed: Revenue ₹232 cr (+14% year on year), EBITDA ₹41.6 cr (+73% year on year), PAT ₹29.3 cr (+266% year on year), EBITDA margin 18.0% (+621 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹218 cr (+7% year on year), EBITDA ₹26.5 cr (+32% year on year), PAT ₹15.7 cr (+293% year on year), EBITDA margin 12.2% (+236 bps). Score 69 of 100, Above trend. Revenue and EBITDA growth were in line with the company's own trend; profit growth was well above it. EBITDA margin rose 236 bps year on year. Tax rate 11%. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −4.6% in 30 days (Nifty 500: +1.6%).
  • Q3 FY26: Revenue ₹159 cr (−15% year on year), EBITDA ₹15.6 cr (−3% year on year), PAT ₹3.6 cr (−58% year on year), EBITDA margin 9.8% (+123 bps). Score 38 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit before exceptional items growth were in line with it. EBITDA margin rose 123 bps year on year. Consolidated profit -27% but standalone +21%. Profit fell 64% from last quarter. Share price after the results: −22.3% in 28 days (Nifty 500: −8.2%).
  • Q2 FY26: Revenue ₹157 cr (−2% year on year), EBITDA ₹21.0 cr (+300% year on year), PAT ₹6.0 cr, EBITDA margin 13.4% (+1,000 bps). Score 68 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA growth was well above it. EBITDA margin rose 1000 bps year on year. Revenue fell 23% from last quarter. Share price after the results: −5.5% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹204 cr (+21% year on year), EBITDA ₹24.0 cr (+50% year on year), PAT ₹8.0 cr, EBITDA margin 11.8% (+224 bps). Score 71 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA growth was in line with it. EBITDA margin rose 224 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +4.0% in 30 days (Nifty 500: +2.2%).
  • Q4 FY25: Revenue ₹204 cr (+15% year on year), EBITDA ₹20.0 cr, PAT ₹4.0 cr, EBITDA margin 9.8% (+1,000 bps). Score 67 of 100, Above trend. Revenue growth was above the company's own trend. EBITDA margin rose 1000 bps year on year. Tax rate 43%. Profit fell 20% from last quarter. Share price after the results: +7.9% in 29 days (Nifty 500: +2.0%).
  • Q3 FY25: Revenue ₹187 cr (+33% year on year), EBITDA ₹16.0 cr (+300% year on year), PAT ₹5.0 cr, EBITDA margin 8.6% (+572 bps). Score 88 of 100, Above trend. Revenue and EBITDA growth were well above the company's own trend. EBITDA margin rose 572 bps year on year. Other income 83% of PBT.
  • Q2 FY25: Revenue ₹160 cr (−21% year on year), EBITDA ₹2.0 cr (−87% year on year), PAT −₹12.0 cr (−300% year on year), EBITDA margin 1.3% (−614 bps). Score 0 of 100, Below trend. EBITDA margin fell 614 bps year on year. Not enough history for a trend yet: scored on growth alone. Revenue fell 5% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Valiant Organics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.